| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 333 | 2019 |
| Transmission of drug-resistant HIV-1 is stabilizing in Europe J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ... The Journal of infectious diseases 200 (10), 1503-1508, 2009 | 313 | 2009 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ... Retrovirology 10, 1-13, 2013 | 181 | 2013 |
| Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials JT Maringwa, C Quinten, M King, J Ringash, D Osoba, C Coens, ... Supportive Care in Cancer 19, 1753-1760, 2011 | 175 | 2011 |
| Relating increasing hantavirus incidences to the changing climate: the mast connection J Clement, J Vercauteren, WW Verstraeten, G Ducoffre, JM Barrios, ... International Journal of Health Geographics 8, 1-11, 2009 | 155 | 2009 |
| Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings RZ Sangeda, F Mosha, M Prosperi, S Aboud, J Vercauteren, RJ Camacho, ... BMC public health 14, 1-11, 2014 | 116 | 2014 |
| Algorithms for the interpretation of HIV-1 genotypic drug resistance information J Vercauteren, AM Vandamme Antiviral research 71 (2-3), 335-342, 2006 | 86 | 2006 |
| CRF19_cpx is an evolutionary fit HIV-1 variant strongly associated with rapid progression to AIDS in Cuba V Kouri, R Khouri, Y Alemán, Y Abrahantes, J Vercauteren, ... EBioMedicine 2 (3), 244-254, 2015 | 85 | 2015 |
| Primary resistance to integrase strand-transfer inhibitors in Europe M Casadellà, PM Van Ham, M Noguera-Julian, A vAn Kessel, C Pou, ... Journal of antimicrobial chemotherapy 70 (10), 2885-2888, 2015 | 81 | 2015 |
| Higher proportion of G2P [4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic … J Matthijnssens, M Zeller, E Heylen, S De Coster, J Vercauteren, ... Clinical Microbiology and Infection 20 (10), O702-O710, 2014 | 79 | 2014 |
| Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania F Mosha, V Muchunguzi, M Matee, RZ Sangeda, J Vercauteren, ... BMC public health 13, 1-7, 2013 | 77 | 2013 |
| Transmission of drug-resistant HIV-1 in Europe remains limited to single classes AMJ Wensing, J Vercauteren, DA van de Vijver, J Albert, B Asjo, C Balotta, ... Aids 22 (5), 625-635, 2008 | 71 | 2008 |
| The global spread of HIV-1 subtype B epidemic G Magiorkinis, K Angelis, I Mamais, A Katzourakis, A Hatzakis, J Albert, ... Infection, genetics and evolution 46, 169-179, 2016 | 70 | 2016 |
| Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ... The Lancet HIV 7 (11), e772-e781, 2020 | 66 | 2020 |
| Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment MCF Prosperi, A Altmann, M Rosen-Zvi, E Aharoni, G Borgulya, F Bazso, ... Antiviral therapy 14 (3), 433-442, 2009 | 65 | 2009 |
| The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal J Vercauteren, K Deforche, K Theys, M Debruyne, LM Duque, S Peres, ... Retrovirology 5, 1-8, 2008 | 65 | 2008 |
| Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia K Angelis, J Albert, I Mamais, G Magiorkinis, A Hatzakis, O Hamouda, ... The Journal of infectious diseases 211 (11), 1735-1744, 2015 | 64 | 2015 |
| Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ... BMC Infectious Diseases 14, 1-12, 2014 | 59 | 2014 |
| Patterns of transmitted HIV drug resistance in Europe vary by risk group D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L Jørgensen, ... PloS one 9 (4), e94495, 2014 | 52 | 2014 |
Anne-Mieke VandammeFull professor, KU Leuven, BelgiumBestätigte E-Mail-Adresse bei uzleuven.be
